{"id":37700,"date":"2023-11-16T14:41:45","date_gmt":"2023-11-16T14:41:45","guid":{"rendered":"https:\/\/www.ersnet.org\/?p=37700"},"modified":"2023-11-16T17:11:08","modified_gmt":"2023-11-16T17:11:08","slug":"proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction","status":"publish","type":"post","link":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/","title":{"rendered":"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

The European Respiratory Society (ERS), with the support of the European Lung Foundation (ELF), has responded positively to the proposed revision to the EU general pharmaceutical legislation, stating that the proposal is a \u201cstep in the right direction\u201d, with clear benefits to patients across Europe, if adopted.\u00a0<\/p>\n","protected":false},"author":16603,"featured_media":37701,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_oasis_is_in_workflow":0,"_oasis_original":0,"_oasis_task_priority":"","footnotes":""},"categories":[22],"tags":[],"class_list":["post-37700","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\nProposed revision to the EU general pharmaceutical legislation is a step in the right direction - ERS - European Respiratory Society<\/title>\n<meta name=\"description\" content=\"Leading Tuberculosis (TB) drug developer, UNITE4TB, of which ERS is a consortium member, has today announced the start of its Phase 2B\/C clinical trial program.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction\" \/>\n<meta property=\"og:description\" content=\"The European Respiratory Society (ERS), with the support of the European Lung Foundation (ELF), has responded positively to the proposed revision to the EU general pharmaceutical legislation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/\" \/>\n<meta property=\"og:site_name\" content=\"ERS - European Respiratory Society\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-16T14:41:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-16T17:11:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1820\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Joe Bamford\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction\" \/>\n<meta name=\"twitter:description\" content=\"The European Respiratory Society (ERS), with the support of the European Lung Foundation (ELF), has responded positively to the proposed revision to the EU general pharmaceutical legislation.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Joe Bamford\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/\"},\"author\":{\"name\":\"Joe Bamford\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/person\/a9ae942c91091cc5a026256a7d88b70a\"},\"headline\":\"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction\",\"datePublished\":\"2023-11-16T14:41:45+00:00\",\"dateModified\":\"2023-11-16T17:11:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/\"},\"wordCount\":15,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.ersnet.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/\",\"url\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/\",\"name\":\"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction - ERS - European Respiratory Society\",\"isPartOf\":{\"@id\":\"https:\/\/www.ersnet.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg\",\"datePublished\":\"2023-11-16T14:41:45+00:00\",\"dateModified\":\"2023-11-16T17:11:08+00:00\",\"description\":\"Leading Tuberculosis (TB) drug developer, UNITE4TB, of which ERS is a consortium member, has today announced the start of its Phase 2B\/C clinical trial program.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#primaryimage\",\"url\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg\",\"contentUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg\",\"width\":1820,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ersnet.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/www.ersnet.org\/news-and-features\/news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ersnet.org\/#website\",\"url\":\"https:\/\/www.ersnet.org\/\",\"name\":\"ERS - European Respiratory Society\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ersnet.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ersnet.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ersnet.org\/#organization\",\"name\":\"European Respiratory Society - ERS\",\"url\":\"https:\/\/www.ersnet.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png\",\"contentUrl\":\"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png\",\"width\":871,\"height\":253,\"caption\":\"European Respiratory Society - ERS\"},\"image\":{\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/person\/a9ae942c91091cc5a026256a7d88b70a\",\"name\":\"Joe Bamford\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.ersnet.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/113f9009971b9151e4ef1e4e75501423253b3d2f517ae0781d133c8b15ea99cf?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/113f9009971b9151e4ef1e4e75501423253b3d2f517ae0781d133c8b15ea99cf?s=96&d=mm&r=g\",\"caption\":\"Joe Bamford\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction - ERS - European Respiratory Society","description":"Leading Tuberculosis (TB) drug developer, UNITE4TB, of which ERS is a consortium member, has today announced the start of its Phase 2B\/C clinical trial program.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/","og_locale":"en_GB","og_type":"article","og_title":"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction","og_description":"The European Respiratory Society (ERS), with the support of the European Lung Foundation (ELF), has responded positively to the proposed revision to the EU general pharmaceutical legislation.","og_url":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/","og_site_name":"ERS - European Respiratory Society","article_published_time":"2023-11-16T14:41:45+00:00","article_modified_time":"2023-11-16T17:11:08+00:00","og_image":[{"width":1820,"height":1024,"url":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg","type":"image\/jpeg"}],"author":"Joe Bamford","twitter_card":"summary_large_image","twitter_title":"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction","twitter_description":"The European Respiratory Society (ERS), with the support of the European Lung Foundation (ELF), has responded positively to the proposed revision to the EU general pharmaceutical legislation.","twitter_image":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg","twitter_misc":{"Written by":"Joe Bamford"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#article","isPartOf":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/"},"author":{"name":"Joe Bamford","@id":"https:\/\/www.ersnet.org\/#\/schema\/person\/a9ae942c91091cc5a026256a7d88b70a"},"headline":"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction","datePublished":"2023-11-16T14:41:45+00:00","dateModified":"2023-11-16T17:11:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/"},"wordCount":15,"commentCount":0,"publisher":{"@id":"https:\/\/www.ersnet.org\/#organization"},"image":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg","articleSection":["News"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/","url":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/","name":"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction - ERS - European Respiratory Society","isPartOf":{"@id":"https:\/\/www.ersnet.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#primaryimage"},"image":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg","datePublished":"2023-11-16T14:41:45+00:00","dateModified":"2023-11-16T17:11:08+00:00","description":"Leading Tuberculosis (TB) drug developer, UNITE4TB, of which ERS is a consortium member, has today announced the start of its Phase 2B\/C clinical trial program.","breadcrumb":{"@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#primaryimage","url":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg","contentUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2023\/11\/EU-general-pharmaceutical-legislation-Twitter.jpg","width":1820,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/www.ersnet.org\/news-and-features\/news\/proposed-revision-to-the-eu-general-pharmaceutical-legislation-is-a-step-in-the-right-direction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ersnet.org\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.ersnet.org\/news-and-features\/news\/"},{"@type":"ListItem","position":3,"name":"Proposed revision to the EU general pharmaceutical legislation is a step in the right direction"}]},{"@type":"WebSite","@id":"https:\/\/www.ersnet.org\/#website","url":"https:\/\/www.ersnet.org\/","name":"ERS - European Respiratory Society","description":"","publisher":{"@id":"https:\/\/www.ersnet.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ersnet.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.ersnet.org\/#organization","name":"European Respiratory Society - ERS","url":"https:\/\/www.ersnet.org\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png","contentUrl":"https:\/\/www.ersnet.org\/wp-content\/uploads\/2021\/01\/ERS-logo-full.png","width":871,"height":253,"caption":"European Respiratory Society - ERS"},"image":{"@id":"https:\/\/www.ersnet.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.ersnet.org\/#\/schema\/person\/a9ae942c91091cc5a026256a7d88b70a","name":"Joe Bamford","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.ersnet.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/113f9009971b9151e4ef1e4e75501423253b3d2f517ae0781d133c8b15ea99cf?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/113f9009971b9151e4ef1e4e75501423253b3d2f517ae0781d133c8b15ea99cf?s=96&d=mm&r=g","caption":"Joe Bamford"}}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts\/37700","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/users\/16603"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/comments?post=37700"}],"version-history":[{"count":3,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts\/37700\/revisions"}],"predecessor-version":[{"id":37730,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/posts\/37700\/revisions\/37730"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/media\/37701"}],"wp:attachment":[{"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/media?parent=37700"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/categories?post=37700"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ersnet.org\/wp-json\/wp\/v2\/tags?post=37700"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}